St. Elizabeth Healthcare has been named a Care Continuum Center of Excellence (CCCOE) by the GO2 Foundation for Lung Cancer. With this designation, St. Elizabeth becomes one of more than 30 community hospitals recognized by the GO2 Foundation for providing patient-focused, comprehensive multidisciplinary lung cancer care.
To qualify for CCCOE status, a community hospital must meet rigorous qualifying criteria that ensures they are providing the highest level of patient care. Recognized programs offer a comprehensive range of services that span all phases of lung cancer screening, diagnosis, treatment and follow up.
At St. Elizabeth this includes:
Dr. Michael Gieske
• Care from nationally known leaders in lung cancer care.
• The expertise of two nurse navigators to guide patients though the care they require.
• A multidisciplinary team approach that encompasses all areas of patient education and care options.
• Weekly meetings of the Nodule Review Board that foster collaboration and teamwork between the
various specialties involved in cancer screening, diagnosis and treatment.
• Molecular biomarker testing that enables personalized treatment tailored to your genetic makeup.
• Minimally invasive biopsy methods and surgical techniques for faster recovery, fewer complications and better results.
• Access to the newest therapies and latest clinical trials for advanced care that’s on the forefront of technology and treatments.
• Education and support to help patients make informed decisions with the best outcome possible.
• The St. Elizabeth Cancer Center, a 250,000 square-foot state-of-the-art facility designed with
these patient needs in mind, is scheduled to open in fall 2020 to provide advanced cancer care in the Northern Kentucky and Greater Cincinnati region.
The CCCOE designation underscores St. Elizabeth’s commitment to reduce the high rate of lung cancer common in our region. Since its launch in 2013, St. Elizabeth’s successful Lung Cancer Screening Program has taken direct aim at the area’s high lung cancer rates, completing more than 11,000 screenings and identifying more than 100 lung cancers under Stage III, when treatment is most effective.
New Cancer Care Center, under construction in Edgewood.
St. Elizabeth previously earned and continues to maintain designations as a Screening Center of Excellence and Diagnostic Imaging Center of Excellence. As a CCCOE, we take that one step further to bring our patients access to high-quality lung cancer services without traveling to a large academic or research institution.
The honor provides St. Elizabeth the opportunity to:
• Collaborate with other CCCOE programs to share best practices and learnings to ensure the highest quality care.
• Access education and support resources for patients, caregivers and healthcare professionals.
• Expand research and clinical study opportunities.
• Participate in the CCCOE Impact Study, which identifies opportunities for quality improvements
within the System and provides comparative analysis of performance.
“We are proud and honored to be working with St. Elizabeth Healthcare as a GO2 Foundation Care Continuum Center of Excellence. Their commitment will help save lives and improve long-term survivorship by giving patients access to high-quality, multidisciplinary care close to home. They are the example to follow,” said Laurie Fenton Ambrose, Co-Founder and President of GO2 Foundation.
“The team-based approach that we have is really key,” said Dr. Michael Gieske, Director of Lung Cancer Screening and Lead Physician, Ft. Mitchell St. Elizabeth Physicians. “It prevents patients from getting lost in the System and experiencing delays in their care. Our process can shave months off the time it takes to access care.”
